Xention to Study Biomarkers for AF Network | GenomeWeb

By a GenomeWeb Staff Reporter

NEW YORK (GenomeWeb News) – Xention will study biomarkers to support the European Network for Translational Research in Atrial Fibrillation (EUTRAF), which has received a €12 million ($16.7 million) grant from the European Union to research this disorder, the company said today.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: role for epigenetic in neuronal excitability, and more.

The new Office of Research Integrity director is grappling with complaints from her staff, according to ScienceInsider.

Italian researchers link SNPs in the PDSS2 gene to coffee consumption in a new paper.

A gene-editing ban has been interpreted to include mitochondrial transfer, Technology Review reports.